Dasatinib is associated with durable treatment responses in chronic phase chronic myeloid leukemia: Long-term follow-up from the phase I trial (Ca180002) Meeting Abstract

  


Authors: Cortes, J.; Sawyers, C. L.; Kantarjian, H. M.; Shah, N. P.; Paquette, R.; Bleickardt, E.; Paliwal, P.; Talpaz, M.
Abstract Title: Dasatinib is associated with durable treatment responses in chronic phase chronic myeloid leukemia: Long-term follow-up from the phase I trial (Ca180002)
Meeting Title: 13th Congress of the European Hematology Association (EHA)
Journal Title: Haematologica
Volume: 93
Issue: Suppl. 1
Meeting Dates: 2008 Jun 12-15
Meeting Location: Copenhagen, Denmark
ISSN: 0390-6078
Publisher: Ferrata Storti Foundation  
Date Published: 2008-07-01
Start Page: 47
Language: English
ACCESSION: WOS:000263430200120
PROVIDER: wos
Notes: --- - Meeting Abstract: 0119 - Poster Session I -- 13th Congress of the European-Hematology-Association - JUN 12-15, 2008 - Copenhagen, DENMARK - "Source: Wos"